Market revenue in 2022 | USD 5,452.7 million |
Market revenue in 2030 | USD 10,083.9 million |
Growth rate | 8% (CAGR from 2022 to 2030) |
Largest segment | Kits & reagents |
Fastest growing segment | Enzymes |
Historical data covered | 2018 - 2021 |
Base year for estimation | 2022 |
Forecast period covered | 2023 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Kits & Reagents, Enzymes |
Key market players worldwide | Thermo Fisher Scientific Inc, Illumina Inc, Agilent Technologies Inc, Qiagen NV, New England Biolabs, Merck KGaA, Roche Holding AG ADR, Bio-Rad Laboratories Inc, Takara Bio Inc, LGC Group, Bausch Health Companies Inc, Promega |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to molecular biology enzymes, reagents and kits market will help companies and investors design strategic landscapes.
Kits & reagents was the largest segment with a revenue share of 67.47% in 2022. Horizon Databook has segmented the Europe molecular biology enzymes, reagents and kits market based on kits & reagents, enzymes covering the revenue growth of each sub-segment from 2018 to 2030.
Europe ranked second after North America in molecular biology enzymes, kits, and reagents market with 27.35% revenue share in 2019. This can be attributed to increasing research funding, growing biotechnology industry, and rising investments in genomic sequencing in countries such as the UK and Germany.
Furthermore, European Molecular Biology Laboratory is a flagship laboratory in Europe, which is associated with more than 80 research groups working in molecular biology arena. Moreover, various conferences, such as the International Molecular Diagnostics Europe organized in May 2019, are expected to increase the adoption of molecular diagnostics in European region.
In addition, the European Commission is providing funding for developing various diagnostic tests and projects related to disease modeling. For instance, in June 2019, European Fund for Strategic Investments (EFSI) provided a 4-year loan to Mobidiag, Inc. to develop and commercialize diagnostic platforms for small laboratories.
Horizon Databook provides a detailed overview of continent-level data and insights on the Europe molecular biology enzymes, reagents and kits market , including forecasts for subscribers. This continent databook contains high-level insights into Europe molecular biology enzymes, reagents and kits market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account